LOCERYL 5 % Medicated nail lacquer Bottle/2,5ml+spatula

Amorolfine hydrochloride..........................................................................................................................5,574 g

Quantity corresponding to amorolfine base.............................................................................................5,000 g

For 100 ml.

Excipient with known effects:

This medicine contains 0,552g of alcohol (ethanol) in each gram of lacquer, which is equivalent to 55,2% w/w.

First-line treatment of onychomycosis without matrix involvement.

Dosage :

Apply LOCERYL to the affected nails at a dosage of once or twice per week.

Method of administration :

To apply the lacquer, carefully follow the recommendations below:

For packs without accessories:

a) Before the first application of LOCERYL, carefully clean the nails and file the affected area of the nail (in particular the nail surface) with a nail file as completely as possible.

Take care not to file the periungual skin.

b) Clean the nail surface and degrease it using a compress or a cloth soaked in solvent.

c) Apply the lacquer using one of the reusable spatulas over the entire affected nail. Clean the reusable spatula between each nail to avoid contaminating the lacquer. Do not wipe the spatula on the rim of the bottle.

d) It is important to thoroughly clean the spatula using a compress or a cloth soaked in solvent after each application, before reusing it on another nail, to avoid contaminating the lacquer.

e) If lacquer has been deposited on the outside of the stopper during handling, it is important to clean it using a compress or a cloth soaked in solvent, to avoid applying this lacquer to the skin.

f) Seal the bottle airtight.

Repeat all of the above steps for each affected nail.

Cosmetic nail varnishes may be applied at least 10 minutes after application of LOCERYL lacquer.

Treatment must be continued without interruption until complete regeneration of the nail and clinical and mycological cure of the affected areas.

The duration of treatment is generally 6 months for fingernails and 9 months for toenails (it depends essentially on the severity and location of the infection and the extent of nail involvement).

Special instructions:

• Do not reuse nail files on healthy nails.
• Before each new application, file the affected nails if necessary and in all cases clean them with nail polish remover to remove residual varnish.
• When handling organic solvents (white spirit, thinners…), it is necessary to wear waterproof gloves to protect the LOCERYL nail varnish layer on the nails.

For packs with accessories:

a) Before the first application of LOCERYL, carefully clean the nails and file the affected area of the nail (in particular the nail surface) with a nail file as completely as possible.

Take care not to file the periungual skin.

b) Clean the nail surface and degrease it using one of the cleansing wipes provided, to remove any trace of residual varnish.

c) Apply the lacquer using one of the reusable spatulas over the entire affected nail. Clean the reusable spatula between each nail to avoid contaminating the lacquer. Do not wipe the spatula on the rim of the bottle.

d) It is important to thoroughly clean the spatula using one of the cleansing wipes provided after each application, before reusing it on another nail, to avoid contaminating the varnish.

e) If varnish has been deposited on the outside of the cap during handling, it is important to clean it using one of the cleansing wipes provided, to avoid applying this varnish to the skin.

f) Reseal the bottle tightly.

Repeat all of the above steps for each affected nail.

Cosmetic nail varnishes may be applied at least 10 minutes after application of LOCERYL lacquer.

Treatment must be continued without interruption until complete regeneration of the nail and clinical and mycological cure of the affected areas.

The duration of treatment is generally 6 months for fingernails and 9 months for toenails (it depends essentially on the severity and location of the infection and the extent of nail involvement).

Special instructions:

• Do not reuse nail files on healthy nails.
• Before each new application, file the affected nails if necessary and in all cases clean them with the cleansing wipes to remove residual varnish.
• When handling organic solvents (white spirit, thinners…), it is necessary to wear waterproof gloves to protect the LOCERYL nail varnish layer on the nails.

Hypersensitivity to the active substance or to any of the excipients listed in section Composition.

Special warnings :

Avoid any contact of LOCERYL with the eyes, ears or mucous membranes.

LOCERYL should be used with caution in patients with conditions predisposing to nail disorders (peripheral circulatory disorders, diabetes, diseases of the immune system) as well as in patients with nail dystrophy or severely damaged nails (more than two thirds of the nail plate is affected). In these cases a systemic treatment should be considered.

Do not use artificial nails during the use of LOCERYL.

If organic solvents are handled, waterproof gloves must be worn, otherwise the varnish will be dissolved.

After application of LOCERYL nail varnish, a period of at least 10 minutes must be observed before applying a cosmetic nail varnish. Before repeating the application of LOCERYL nail varnish, the cosmetic nail varnish must be carefully removed.

A systemic or local allergic reaction could possibly occur after use of this medicine. If this occurs, the medicine must be stopped immediately and a doctor must be consulted. Carefully remove the product using nail polish remover. The medicine must not be reused.

This medicine contains ethanol, which may cause a burning sensation on damaged skin. Ethanol is a flammable substance and must not be used near a flame, a lit cigarette or certain appliances (for example hair dryers).

Precautions for use

In the absence of data, the use of LOCERYL is not recommended in patients under 18 years of age.

The data available to date do not suggest the existence of clinically significant interactions.

There are limited data on the use of amorolfine in pregnant and breastfeeding women. Only a small number of pregnancies exposed to topical amorolfine have been reported after marketing, so the potential risk is unknown.

Studies performed in animals have shown reproductive toxicity at high oral doses (see section Preclinical safety).

It is not known whether amorolfine is excreted in human milk.

LOCERYL must not be used during pregnancy and breast-feeding, except in cases of real necessity.

*Adverse effects reported since marketing.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: www.signalement-sante.gouv.fr.

No systemic signs of overdose are expected after topical application of LOCERYL.

In case of accidental ingestion, appropriate symptomatic measures should be taken.

Pharmacotherapeutic class: OTHER ANTIFUNGALS FOR TOPICAL USE, ATC code: D01AE16.

LOCERYL is a topical antimycotic. The active ingredient, amorolfine, a morpholine derivative, belongs to a new chemical class of antimycotics.

Its fungistatic and fungicidal effect is based on an alteration of the fungal cell membrane mainly targeting sterol biosynthesis.

The ergosterol content is reduced. An accumulation of atypical sterols leads to morphological changes in cell membranes and organelles that cause the death of the fungal cell.

Amorolfine has a broad antifungal spectrum. It is highly effective against the usual or occasional agents of onychomycoses:

• Yeasts:
  •        Candida albicans and other Candida species.
• Dermatophytes:
  • Trichophyton rubrum, Trichophyton interdigitale and Trichophyton mentagrophytes, other species of Trichophyton,
  • Epidermophyton floccosum,
  • Microsporum.
• Moulds:
  • Scopulariopsis.
• Dematiaceous fungi (black fungi):
  • Hendersonula, Alternaria, Cladosporium.
• Less sensitive species:

Aspergillus, Fusarium, mucorales.

Amorolfine in the form of a nail lacquer penetrates and diffuses through the nail plate and is able to eradicate fungi that are poorly accessible in the nail bed.

The general absorption of the active ingredient is negligible, with the plasma concentration remaining below the sensitivity threshold, even after one year of use.

In rats, amorolfine is not teratogenic and is not embryotoxic at the maximum oral dose tested of 40 and 80 mg/kg/day. However, signs of maternal toxicity (weight loss) were observed at doses of 40 and 80 mg/kg/day.

In rabbits, amorolfine is not teratogenic but has an embryotoxic effect at the maximum oral dose tested of 10 mg/kg/day. Maternal weight loss, reflecting maternal toxicity, was also observed at the dose of 10 mg/kg/day.

Due to the very low systemic absorption of amorolfine following application to the nail or skin, the potential risk of toxicity to the human fetus is negligible.

3 years

Store away from heat.

No particular requirements

• Indication(s) appearing in the marketing authorisation at the date of publication of this decree